Real-World Outcomes of Ipilimumab Plus Nivolumab for Metastatic Renal Cell Carcinoma: A National Population-Based Cohort Study
Chin Hang Yiu, Adrian Lee, Christine Y. Lu
Topics & Concepts
MedicineIpilimumabNivolumabOncologyInternal medicineClinical trialRenal cell carcinomaCohort studyCohortRetrospective cohort studyKidney cancerMEDLINEExpanded accessMetastatic melanomaOverall survivalStandard of careImmunotherapySystemic therapyIntensive care medicineComparative effectiveness researchDiseaseHealth careCancerResearch designReal world dataRenal cell carcinoma treatmentCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis